Baidu cracks down on false advertising
Baidu Tieba, an online community, has ended commercial relationships in its medical sector over complaints of blatant and fake advertising.
Baidu Tieba functions by having users creating a tieba, or forum, under a specific topic.
On January 9 a user called Mayicai said his role as administrator of the hemophilia forum had been replaced by so-called expert Liu Shanxi, who had been exposed as a quack doctor in 2014.
On Monday, another post claimed that 40 percent of 3,259 forums on various diseases had been sold to unlicensed hospitals, quack doctors and drugs manufacturers, who were using the platforms to promote their products.
A forum on high blood pressure, with more than 50,000 followers, was being administered by Gemei TCM, a Guangzhou-based bio-technology company which sells health supplements.
Screenshots showed that Gemei was telling patients that its medicines were effective and advising them not to see doctors.
According to Beijing Youth Daily, a year鈥檚 administration rights of a disease-related forum were being sold for at least 200,000 yuan (US$30,420).
Yesterday, Baidu issued a statement saying: 鈥淢any patients gather at disease-titled forums to discuss their disease and share information. And thus such forums greatly concern users鈥 health. But some administrators violate rules and take advantage of their posts to publicize commercial information and seek personal interests.鈥
Disease-related forums are only allowed to partner with professional and reputable non-profit organizations, it added.
The administrator of the hemophilia forum has now been replaced by the non-profit Hemophilia Home of China.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.